1: Osterman IA, Wieland M, Maviza TP, Lashkevich KA, Lukianov DA, Komarova ES, Zakalyukina YV, Buschauer R, Shiriaev DI, Leyn SA, Zlamal JE, Biryukov MV, Skvortsov DA, Tashlitsky VN, Polshakov VI, Cheng J, Polikanov YS, Bogdanov AA, Osterman AL, Dmitriev SE, Beckmann R, Dontsova OA, Wilson DN, Sergiev PV. Tetracenomycin X inhibits translation by binding within the ribosomal exit tunnel. Nat Chem Biol. 2020 Oct;16(10):1071-1077. doi: 10.1038/s41589-020-0578-x. Epub 2020 Jun 29. PMID: 32601485.
2: Cecilia MK, Abrha AH, Hlengilizwe N, Hintsa AT, Umer M, Nixwell MF, Ali SW, Afzal MI, Martorell M, Salehi B, Setzer WN, Sattar MU, Imran M, Sharifi-Rad J. Untargeted profiling of field cultivated bush tea (Athrixia phylicoides DC.) based on metabolite analysis. Cell Mol Biol (Noisy-le-grand). 2020 Jun 25;66(4):104-109. PMID: 32583775.
3: Qiao X, Gan M, Wang C, Liu B, Shang Y, Li Y, Chen S. Tetracenomycin X Exerts Antitumour Activity in Lung Cancer Cells through the Downregulation of Cyclin D1. Mar Drugs. 2019 Jan 18;17(1):63. doi: 10.3390/md17010063. PMID: 30669360; PMCID: PMC6357012.
4: Liu B, Tan Y, Gan ML, Zhou HX, Wang YG, Ping YH, Li B, Yang ZY, Xiao CL. [Identification of tetracenomycin X from a marine-derived Saccharothrix sp. guided by genes sequence analysis]. Yao Xue Xue Bao. 2014 Feb;49(2):230-6. Chinese. PMID: 24761614.
5: Anderson MG, Khoo CL, Rickards RW. Oxidation processes in the biosynthesis of the tetracenomycin and elloramycin antibiotics. J Antibiot (Tokyo). 1989 Apr;42(4):640-3. doi: 10.7164/antibiotics.42.640. PMID: 2722677.